TY  - GEN
AU  - Puymirat,E
AU  - Cohen,S
AU  - Védrenne,G
AU  - Caruba,T
AU  - Sabatier,B
AU  - Danchin,N
AU  - Durand,E
TI  - Cost analysis of bivalirudin versus reference anticoagulants without GP IIb/IIIa inhibitors in patients undergoing percutaneous coronary intervention for acute coronary syndrome in routine clinical practice. Pompidou registry
SN  - 1768-3181
PY  - 2013///1209
KW  - Acute Coronary Syndrome
KW  - economics
KW  - Aged
KW  - Aged, 80 and over
KW  - Anticoagulants
KW  - Antithrombins
KW  - Cost-Benefit Analysis
KW  - Drug Costs
KW  - Female
KW  - Heparin
KW  - Hirudins
KW  - Hospitals, University
KW  - Humans
KW  - Length of Stay
KW  - Male
KW  - Middle Aged
KW  - Paris
KW  - Peptide Fragments
KW  - Percutaneous Coronary Intervention
KW  - Platelet Glycoprotein GPIIb-IIIa Complex
KW  - antagonists & inhibitors
KW  - Prospective Studies
KW  - Recombinant Proteins
KW  - Registries
KW  - Treatment Outcome
N1  - Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1016/j.ancard.2012.10.002
ER  -